AU2001254710A1 - Non-steroidal, tetracyclic compounds for estrogen-related treatments - Google Patents
Non-steroidal, tetracyclic compounds for estrogen-related treatmentsInfo
- Publication number
- AU2001254710A1 AU2001254710A1 AU2001254710A AU5471001A AU2001254710A1 AU 2001254710 A1 AU2001254710 A1 AU 2001254710A1 AU 2001254710 A AU2001254710 A AU 2001254710A AU 5471001 A AU5471001 A AU 5471001A AU 2001254710 A1 AU2001254710 A1 AU 2001254710A1
- Authority
- AU
- Australia
- Prior art keywords
- estrogen
- alkenyl
- alkyl
- compounds
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/21—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201103 | 2000-03-27 | ||
EP00201105 | 2000-03-27 | ||
EP00201103 | 2000-03-27 | ||
EP00201105 | 2000-03-27 | ||
PCT/EP2001/003187 WO2001072713A1 (en) | 2000-03-27 | 2001-03-21 | Non-steroidal, tetracyclic compounds for estrogen-related treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001254710A1 true AU2001254710A1 (en) | 2001-10-08 |
Family
ID=26072045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001254710A Abandoned AU2001254710A1 (en) | 2000-03-27 | 2001-03-21 | Non-steroidal, tetracyclic compounds for estrogen-related treatments |
Country Status (9)
Country | Link |
---|---|
US (1) | US6686371B2 (de) |
EP (1) | EP1272471B1 (de) |
JP (2) | JP2003528858A (de) |
AT (1) | ATE374752T1 (de) |
AU (1) | AU2001254710A1 (de) |
DE (1) | DE60130748T2 (de) |
ES (1) | ES2293986T3 (de) |
PE (1) | PE20011131A1 (de) |
WO (1) | WO2001072713A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5209600A (en) * | 1999-04-06 | 2000-10-23 | Akzo Nobel N.V. | Orally active androgens |
ATE309208T1 (de) | 2000-08-23 | 2005-11-15 | Akzo Nobel Nv | 10-aryl-11h-benzo(b)fluoren-derivate und analoga als östrogene mittel |
EP1418900A4 (de) * | 2001-08-13 | 2006-01-25 | Merck & Co Inc | Selektive östrogen-rezeptor-modulatoren |
WO2003044006A1 (en) | 2001-11-19 | 2003-05-30 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
TW200408385A (en) * | 2001-12-21 | 2004-06-01 | Akzo Nobel Nv | Tetrahydrobenzfluorene derivatives |
TW200304371A (en) | 2002-02-22 | 2003-10-01 | Akzo Nobel Nv | Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors |
US6849348B2 (en) * | 2002-12-31 | 2005-02-01 | Eastman Kodak Company | Complex fluorene-containing compounds |
US7279499B2 (en) | 2003-04-21 | 2007-10-09 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
WO2004094400A2 (en) | 2003-04-21 | 2004-11-04 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
JP2008512458A (ja) | 2004-09-07 | 2008-04-24 | ワイス | 6H−[1]ベンゾピラノ[4,3−b]キノリン及びエストロゲン様物質としてのそれらの使用 |
JP6263631B2 (ja) * | 2014-08-27 | 2018-01-17 | 富士フイルム株式会社 | 組成物、膜、光学機器、化合物 |
CN104327088A (zh) * | 2014-09-24 | 2015-02-04 | 大连理工大学 | 一种7-氯-6H-苯并吡喃[4,3-b]喹啉及其衍生物的制备方法 |
CN104262357B (zh) * | 2014-09-24 | 2017-05-03 | 大连理工大学 | 一种7‑氯‑6H‑苯并噻喃[4,3‑b]喹啉及其衍生物的制备方法 |
CN104292243A (zh) * | 2014-09-24 | 2015-01-21 | 大连理工大学 | 一种苯并噻喃[4,3-b]喹啉及其衍生物的制备方法 |
CN108947947A (zh) * | 2017-05-17 | 2018-12-07 | 北京新领先医药科技发展有限公司 | 一种沃拉帕沙中间体的制备方法 |
CN115785148A (zh) * | 2022-11-17 | 2023-03-14 | 江西科技师范大学 | 一种硫代膦(磷)酸酯取代苯并芴化合物的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223506A (en) * | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
US5147880A (en) * | 1991-07-22 | 1992-09-15 | Eli Lilly And Company | Benzo[a]fluorene compounds |
US5693647A (en) * | 1994-12-22 | 1997-12-02 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
JP3141148B2 (ja) * | 1995-08-08 | 2001-03-05 | 大鵬薬品工業株式会社 | 縮合インダン誘導体及びその塩 |
KR20000048537A (ko) * | 1996-09-23 | 2000-07-25 | 루트거스, 더 스테이트 유니버시티 오브 뉴 저지 | 항 종양제로서의 치환된 헤테로사이클 |
WO2004031125A1 (ja) * | 2002-10-01 | 2004-04-15 | Dainippon Pharmaceutical Co., Ltd. | スピロ化合物、それを含有する医薬組成物及び該化合物の中間体 |
-
2001
- 2001-03-21 AT AT01927762T patent/ATE374752T1/de not_active IP Right Cessation
- 2001-03-21 JP JP2001570626A patent/JP2003528858A/ja active Pending
- 2001-03-21 WO PCT/EP2001/003187 patent/WO2001072713A1/en active IP Right Grant
- 2001-03-21 EP EP01927762A patent/EP1272471B1/de not_active Expired - Lifetime
- 2001-03-21 DE DE60130748T patent/DE60130748T2/de not_active Expired - Lifetime
- 2001-03-21 AU AU2001254710A patent/AU2001254710A1/en not_active Abandoned
- 2001-03-21 US US10/240,129 patent/US6686371B2/en not_active Expired - Fee Related
- 2001-03-21 ES ES01927762T patent/ES2293986T3/es not_active Expired - Lifetime
- 2001-03-26 PE PE2001000283A patent/PE20011131A1/es not_active Application Discontinuation
-
2009
- 2009-07-31 JP JP2009178534A patent/JP2009292824A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
PE20011131A1 (es) | 2001-11-12 |
JP2003528858A (ja) | 2003-09-30 |
US20030144313A1 (en) | 2003-07-31 |
EP1272471B1 (de) | 2007-10-03 |
WO2001072713A1 (en) | 2001-10-04 |
ES2293986T3 (es) | 2008-04-01 |
DE60130748T2 (de) | 2008-07-17 |
US6686371B2 (en) | 2004-02-03 |
DE60130748D1 (de) | 2007-11-15 |
ATE374752T1 (de) | 2007-10-15 |
EP1272471A1 (de) | 2003-01-08 |
JP2009292824A (ja) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001254710A1 (en) | Non-steroidal, tetracyclic compounds for estrogen-related treatments | |
BR0009814A (pt) | Processo para tratar de uma doença associada com o receptor-beta estrogênico | |
AU7649701A (en) | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents | |
PE134199A1 (es) | Inhibicion de la oxidacion de lipoproteinas | |
ATE192649T1 (de) | Stereochemische wortmanninderivate | |
BR0113053A (pt) | Uso de benzilidenoaminoguanidinas e hidroxiguanidinas como ligantes para os receptores de melanocortina | |
UA83620C2 (ru) | Замещенные бензоксазолы и их аналоги как эстрогенные агенты | |
UA94246C2 (ru) | Производные индазола, которые ингибируют рецептор trpv1 | |
WO2005077968A8 (en) | 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity | |
YU43002A (sh) | Metod za hemoprevenciju kancera prostate | |
HU9603584D0 (en) | Sterol derivatives which applicable for regulation of meiosis | |
AU4246501A (en) | 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity | |
BR0112365A (pt) | Combinações de estatinas, agentes estrogênicos e opcionalmente estrogênios | |
BR0215058A (pt) | 2-fenil benzofuranos substituìdos como agentes estrogênicos | |
ES2154560B1 (es) | Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres. | |
AU2001256164A1 (en) | Chroman derivatives as estrogenic compounds | |
ZA200300929B (en) | 17.Beta.-carbothioate 17.Alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents. | |
PL366101A1 (en) | Gel composition and trans/scrotal application of a composition for the treatment of hypogonadism | |
ES2164400T3 (es) | Esteroides con actividad anticonceptiva y antiosteoporotica. | |
ZA200201250B (en) | Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11. | |
ATE277913T1 (de) | Bisarylderivate mit fsh rezeptor modulierender aktivität | |
ATE224883T1 (de) | Indene-derivate mit serm-wirkung | |
WO2000010543A3 (de) | Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung | |
ATE377605T1 (de) | 6-oxygenierte steroid-estrogene mit aromatischen a- und b-ringen | |
HK1052012A1 (en) | 16, 17-Carbocyclic condensed steroid compounds having selective estrogenic activity. |